Data from health insurer reporting in 2021 is now available.
Senate Bill 192 (2023) amended ORS 743.025, expanding which insurers are required to report prescription drug information to the Drug Price Transparency Program starting in 2024.
OAR 836-053-1630 provides additional clarification on which insurers are required to report and which plans to include.
Health insurance companies offering a health benefit plan in Oregon are required to provide information on the top 25 drugs for various categories: most frequently prescribed, most costly, and those causing the greatest increase in plan spending.
Also, health insurance companies are required to report on the effect of prescription drug costs on premiums, including any effect that rebates or price concessions may have on premiums. The lists submitted by the health insurance companies used the template provided below. The information reported to the program was used to compile the aggregate prescription drugs lists below.
Insurer reports are due
May 1. If you have questions or need help, email
DPT.RxReporting@dcbs.oregon.gov.
Insurers who have questions about our reporting can also join our open “office hours” meeting every Thursday from 10:00 – 10:30 AM (Pacific time). This meeting is to answer questions you may have as you gather the data for the report. We will update this page if a meeting needs to be cancelled for that week.
JOIN ONLINE:
Microsoft Teams meeting
Click here to join the meeting
Meeting ID: 287 614 838 050
Passcode: Ge2F8V7m
Or call in (audio only)
+1 503-446-4951,,701648382#
CONFERENCE ID: 701 648 382#
Insurer report data
The program receives reports from health insurance companies that offers a health benefit plan in Oregon. The program usually received reports from nine or 10 companies when reporting was linked to Oregon's annual rate review process. Starting in 2024, reporting was expanded to include additional companies. Check the program’s annual legislative report for analysis of the data collected from insurance companies.
2019 Insurer prescription drug reports